SNANF 0.24 Stock Price Sona Nanotech Inc.
Range: | 0.133-0.408 | Vol Avg: | 3312 | Last Div: | 0 | Changes: | 0 |
Beta: | -1.72 | Cap: | 0.02B | Currency: | USD | Exchange: | PNK |
Sector: | Healthcare | IPO: | Thu Jul 27 2006 | Empoloyees: | 8 |
CUSIP: | | CIK: | | ISIN: | CA83541C1059 | Country: | CA |
CEO: | Mr. David Andrew Regan | Website: | https://www.sonanano.com |
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.